Hester Biosciences Ltd.
| BSE: 524669 | Sector: Health care |
| NSE: HESTERBIO | ISIN Code: INE782E01017 |
| BSE 00:00 | 23 Jul | 2411.55 |
-13.75 (-0.57%) |
OPEN
2415.00 |
HIGH
2433.10 |
LOW
2394.05 |
| NSE 00:00 | 23 Jul | 2411.70 |
-9.10 (-0.38%) |
OPEN
2450.00 |
HIGH
2450.00 |
LOW
2394.05 |
| OPEN | 2415.00 |
| PREVIOUS CLOSE | 2425.30 |
| VOLUME | 689 |
| 52-Week high | 3180.00 |
| 52-Week low | 1246.00 |
| P/E | 47.05 |
| Mkt Cap.(Rs cr) | 2,052 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Hester Biosciences Ltd. (HESTERBIO) - Latest News & Headlines
-
Hester Bio surges 22% in 2 days on tech transfer for manufacturing Covaxin
10.09 am | 28 May 2021 | Business Standard
The technology transfer from Bharat Biotech will enable Hester to provide the drug substance from August 2021 to BB for its vaccine production
-
Hester Biosciences zooms 33% in 2 days as firm in talks to produce Covaxin
9.55 am | 17 May 2021 | Business Standard
The company said it has tied up with the Gujarat government to explore the production of Covid-19 vaccine through technology transfer from Bharat Biot...
Quick Links for Hester Biosciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
